Cargando…

Linking white matter and deep gray matter alterations in premanifest Huntington disease

Huntington disease (HD) is a fatal progressive neurodegenerative disorder for which only symptomatic treatment is available. A better understanding of the pathology, and identification of biomarkers will facilitate the development of disease-modifying treatments. HD is potentially a good model of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faria, Andreia V., Ratnanather, J. Tilak, Tward, Daniel J., Lee, David Soobin, van den Noort, Frieda, Wu, Dan, Brown, Timothy, Johnson, Hans, Paulsen, Jane S., Ross, Christopher A., Younes, Laurent, Miller, Michael I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827723/ https://www.ncbi.nlm.nih.gov/pubmed/27104139 http://dx.doi.org/10.1016/j.nicl.2016.02.014

Ejemplares similares

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington’s disease
por: Hu, Beini, et al.
Publicado: (2023)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Zeun, Paul, et al.
Publicado: (2022)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)

Hearing loss impacts gray and white matter across the lifespan: Systematic review, meta-analysis and meta-regression
por: Manno, Francis A.M., et al.
Publicado: (2021)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Castro, Eduardo, et al.
Publicado: (2018)

Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
por: Olm, Christopher A., et al.
Publicado: (2018)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

Association between gray/white matter contrast and white matter microstructural alterations in medication-naïve obsessive–compulsive disorder
por: Niu, Qihui, et al.
Publicado: (2022)

White and gray matter brain development in children and young adults with phenylketonuria
por: Hawks, Zoë, et al.
Publicado: (2019)

A Critical Review of White Matter Changes in Huntington’s Disease
por: Casella, Chiara, et al.
Publicado: (2020)

Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
por: Casella, Chiara, et al.
Publicado: (2021)

Dissociating regional gray matter density and gray matter volume in autism spectrum condition
por: Yankowitz, Lisa D., et al.
Publicado: (2021)

White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
por: De Paepe, Audrey E., et al.
Publicado: (2019)

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease
por: Jurgens, Caroline K., et al.
Publicado: (2009)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Integrated analysis of gray and white matter alterations in attention-deficit/hyperactivity disorder
por: Francx, Winke, et al.
Publicado: (2016)

Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome
por: Ciarochi, Jennifer Ashley, et al.
Publicado: (2016)

Gray matter microstructure differences in autistic males: A gray matter based spatial statistics study
por: DiPiero, Marissa A., et al.
Publicado: (2022)

Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes
por: Nouwen, Arie, et al.
Publicado: (2017)

Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer’s disease
por: Putcha, Deepti, et al.
Publicado: (2022)

Fusion analysis of gray matter and white matter in subjective cognitive decline and mild cognitive impairment by multimodal CCA-joint ICA
por: Liang, Lingyan, et al.
Publicado: (2021)

Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease
por: Liu, Jingyu, et al.
Publicado: (2018)

Age of gray matters: Neuroprediction of recidivism
por: Kiehl, Kent A., et al.
Publicado: (2018)

Sleep deficits but no metabolic deficits in premanifest Huntington's disease
por: Lazar, Alpar S., et al.
Publicado: (2015)

Mutation‐related magnetization‐transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra‐strong gradient MRI
por: Casella, Chiara, et al.
Publicado: (2022)

Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1
por: Zanigni, Stefano, et al.
Publicado: (2016)

Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington’s disease
por: Liu, Chin-Fu, et al.
Publicado: (2023)

Deep White Matter in Huntington's Disease
por: Phillips, Owen, et al.
Publicado: (2014)

Characterizing White Matter in Huntington's Disease
por: Gregory, Sarah, et al.
Publicado: (2019)

Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease
por: Vaca-Palomares, Israel, et al.
Publicado: (2017)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice
por: Winder, Jessica Y., et al.
Publicado: (2018)

Testing a longitudinal compensation model in premanifest Huntington’s disease
por: Gregory, Sarah, et al.
Publicado: (2018)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Quantitative MRI outcomes in child and adolescent leukemia survivors: Evidence for global alterations in gray and white matter
por: van der Plas, Ellen, et al.
Publicado: (2020)

Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis
por: Steinbach, Robert, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8e7ugub429qlh3lprnphuaftd9